Characteristics of pharmacies; Democratic Republic of the Congo; Kinshasa; Peri-urban areas; Testing and Treatment Algorithm; Pharmaceutical legislation and regulation; Quality of antimalarials
Abstract :
[en] Background: In the context of old pharmaceutical legislation and regulations not adapted to current realities, the aim of the present studywas to evaluate the existing pharmaceutical system in peri-urban areas of Kinshasa.
Methods: A prospective study was carried out during the period 2016–2018. The most used antimalarial medicines were identified through household and pharmaceutical establishment surveys. The samples of the obtained medicines were assayed with generic separation methods using the high-performance liquid chromatography technique coupled to a diode array detector. The registration status was checked for 126 antimalarial brand names. A characterization was carried out in 196 pharmaceutical establishments on the basis of standards set out by the Ministry of Health.
Results: Of the 75 samples assayed, 19% (14/75)were non-compliant. Of the 124 brand names, 46.0% (57/124) were unlicensed and 14.5% (18/124) had an expired licence. Of the 196 pharmaceutical establishments, only 2 (1.0%) had an authorization to practice, none met all the Ministry of Health minimum standards and 24.5% (48/196) met the World Health Organization Guidelines for the Storage of Essential Medicines and Other Health Commodities.
Conclusions: More resources should be mobilized to apply regulator sanctions.
Research center :
CIRM - Centre Interdisciplinaire de Recherche sur le Médicament - ULiège
Marini Djang'eing R, Tshilombo K, Habyalimana V et al. Falsification des médicaments en milieu périurbain: triste réalité. Gembloux: Presses agronomiques de Gembloux; 2015; p. 193-202.
World Health Organization. A study on the public health and socioeconomic impact of substandard and falsified medical products. https://www.who.int/medicines/regulation/ssffc/publications/SEStudy_EN_web.pdf (accessed 19 June 2018).
Arie S. Contaminated drugs are held responsible for 120 deaths in Pakistan. BMJ. 2012;344:e951.
World Health Organization. Substandard and falsified medical products. http://www.who.int/news-room/fact-sheets/detail/substanda rd-and-falsified-medical-products [accessed 26 August 2018].
World Health Organization. 1 in 10 medical products in developing countries is substandard or falsified. http://www.who.int/news-room/detail/28-11-2017-1-in-10-medical-products-in-developingcountries-is-substandard-or-falsified (accessed 26 August 2018).
Newton PN, Green MD, Fernández FM. Impact of poor-quality medicines in the 'developing' world. Trends Pharmacol Sci. 2010; 31(3-3):99-101.
World Health Organization. Counterfeit medicines: an update on estimates. https://www.who.int/medicines/services/counterfeit/impact/TheNewEstimatesCounterfeit.pdf [accessed 27 September 2018].
Tshilombo NK, Hamuli PC, Mbinze JK et al. Investigation of the quality of antibiotics-based amoxicillin for monitoring of some different medicine markets of Democratic Republic of Congo. Am J Analyt Chem. 2018;9:366-85.
Manzambi Kuwekita J, Bruyère O, Guillaume M et al. How to optimize the efficiency of international sanitary aid in the Democratic Republic of Congo. Santé Publique. 2015;27(1):129-34.
Ferrari G, Ntuku HM, Schmidlin S et al. A malaria risk map of Kinshasa, Democratic Republic of Congo. Malar J. 2016;15:27.
Mufusama J-P, Ndjoko Ioset K, Feineis D et al. Quality of the antimalarial medicine artemether-lumefantrine in 8 cities of the Democratic Republic of the Congo. Drug Test Anal. 2018;10(10): 1599-606.
Mutombo HK. Urbanisation et fabrique urbaine à Kinshasa: défis et opportunités d'aménagement. PhD dissertation. Bordeaux: Université Michel de Montaigne - Bordeaux III, 2014.
Kayembe Wa Kayembe M, De Maeyer M, Wolff E. Cartographie de la croissance urbaine de Kinshasa (R.D. Congo) entre 1995 et 2005 par télédétection satellitaire à haute résolution. Belgeo. 2009; 3-4:439-56.
Direction de la Pharmacie et du Médicament. Les médicaments enregistrés en République Démocratique du Congo. http://dpmrdc.org/BASE-DES-DONNEES/Les-medicaments-enregistres-enRepublique-Democratique-du-Congo [accessed 27 August 2018].
Ministère de Santé Publique de la RDC. Plan National de Développement Sanitaire 2016-2020: vers la couverture sanitaire universelle. http://www.nationalplanningcycles.org/sites/default/files/planning_cycle_repository/democratic_republic_of_congo/pnds_2016-2020_ version_finale_29_avril_2016.pdf (accessed 28 August 2018).
Ministère du Plan et Suivi de la Mise en Œuvre de la Révolution de la Modernité, Ministère de Santé Publique. Enquête Démographique et de Santé (EDS-RDC) 2013-2014. https://www.dhsprogram.com/pubs/pdf/FR300/FR300.pdf (accessed 17 February 2018).
ACTwatch Group, Mpanya G, Tshefu A, Likwela JL. The malaria testing and treatment market in Kinshasa, Democratic Republic of the Congo, 2013. Malar J. 2017;16(1):94.
World Health Organization. Guidelines for the storage of essential medicines and other health commodities. http://apps.who.int/medicinedocs/pdf/s4885e/s4885e.pdf (accessed 27 August 2018).
Fadlallah R, El-Jardali F, Annan F et al. Strategies and systems-level interventions to combat or prevent drug counterfeiting: a systematic review of evidence beyond effectiveness. Pharm Med. 2016;30(5): 263-76.
Institute of Medicine. Countering the problem of falsified and substandard drugs. Washington, DC: National Academies Press; 2013.
Ozawa S, Evans DR, Bessias S et al. Prevalence and estimated economic burden of substandard and falsified medicines in low- and middle-income countries: a systematic review and meta-analysis. JAMA Network Open. 2018;1(4): e181662.
Nkoli Mandoko P, Sinou V, Moke Mbongi D et al. Access to artemisinin-based combination therapies and other anti-malarial drugs in Kinshasa. Med Mal Infect. 2018;48(4):269-77.
Ministère de Santé Publique de la RDC. Rapport narratif: profil pharmaceutique de la République Démocratique du Congo 2011. https://www.who.int/medicines/areas/coordination/drc_pharmaceutical_profile.pdf (accessed 28 August 2018).
Direction de la Pharmacie et du Médicament. Plan stratégique du Système National d'Approvisionnement en Médicaments Essentiels « SNAME» 2017-2020. http://dpmrdc.org/Documentations/planstrategique-du-systeme-national-d-approvisionnement-en-medi caments-essentiels-sname-2017-2020 (accessed 28 August 2018).
President's Malaria Initiative. Promoting and ensuring public health through regulatory support in the Democratic Republic of the Congo: medicines registration. https://www.pmi.gov/news/stories-from-thefield/stories-from-the-field-detail/promoting-and-ensuring-publichealth-through-regulatory-support-in-the-democratic-republic-of-the-congo-medicines-registration (accessed 28 August 2018).
Programme National d'Approvisionnement en Médicaments. Cartographie des systèmes d'approvisionnement et de distribution des médicaments et autres produits de santé en RDC. http://apps.who.int/medicinedocs/documents/s17032f/s17032f.pdf (accessed 28 August 2018).
Direction de la Pharmacie et du Médicament. Lignes directrices des bonnes pratiques de distribution applicables en RDC. http://apps.who.int/medicinedocs/documents/s23046fr/s23046fr.pdf (accessed 17 February 2018).
Newton PN, Lee SJ, Goodman C et al. Guidelines for field surveys of the quality of medicines: a proposal. PLoS Med. 2009;6(3):e52.
